GB2424835B — Injection device (modified trigger)
Assigned to Cilag GmbH International · Expires 2010-06-09 · 16y expired
What this patent protects
An injection device is provided which includes a syringe having a discharge nozzle. The syringe is movable between a retracted position in which the discharge nozzle is contained within the housing and an extended position in which the discharge nozzle extends from the housing. A…
USPTO Abstract
An injection device is provided which includes a syringe having a discharge nozzle. The syringe is movable between a retracted position in which the discharge nozzle is contained within the housing and an extended position in which the discharge nozzle extends from the housing. A trigger is activatable to allow the contents of the syringe to be discharged through the discharge nozzle. There is also a releasable locking mechanism which, when engaged, prevents the trigger from moving into an active position. The trigger includes a first portion having a cut-out which extends from a first end of the trigger in a direction substantially parallel to the first axis. The releasable locking mechanism includes a protrusion along a second axis for communicating with the first portion of the trigger when the releasable locking mechanism is engaged and for communicating with the cut-out when the releasable locking mechanism is disengaged. Such an injection device provides improved protection against accidental activation of the trigger.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.